(MedPage Today) — Almost 50 million Americans — 22.2% of adults 18 and older — have physician-diagnosed arthritis, a total that’s expected to rise in the coming decades, according to the CDC.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA announced a plan on Monday to create a network of centers that will help promote its new “regulatory science” agenda.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — Expansion of nurses’ scope of practice is just one of the ways to meet the growing demands for healthcare services created by the Affordable Care Act (ACA) that are detailed in a new report from the Institute of Medicine.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — When it comes to off-road vehicle crashes, four wheels aren’t safer than two, researchers reported.
No Comments »
Filed under: General Health News
Vivaglobin (subcutaneous immunoglobulin [IgG]) (SCIg) is an effective and safe initial therapy for treatment-naive patients with primary immunodeficiency (PI) and may offer an attractive alternative to intravenous IgG (IVIg) therapy in the newly diagnosed, according to data presented today at the XIVth Meeting of the European Society for Immunodeficiencies.
No Comments »
Filed under: Pharmacy News
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced it will present a poster at the 74th Annual Scientific Meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP), to be held November 7-11, 2010 in Atlanta, Georgia.
No Comments »
Filed under: Pharmacy News
Integra LifeSciences Holdings Corporation announced today that the results of the multi-center human clinical trial comparing NeuraGen Nerve Guide with direct suture repair have been accepted, in abstract form, for presentation at the joint meeting of the American Association for Hand Surgery (AAHS), American Society for Reconstructive Microsurgery (ASRM), and American Society for Peripheral Nerve [...]
No Comments »
Filed under: Pharmacy News
Privigen, the first and only 10% liquid intravenous immunoglobulin (IVIg) therapy stabilized with proline, is effective and well tolerated in patients with several primary and secondary immunodeficiencies, according to data presented today at the XIVth Meeting of the European Society for Immunodeficiencies. Results also demonstrate that Privigen offers significant protection against infection.
No Comments »
Filed under: Pharmacy News
Hizentra (IgPro20) provides primary immunodeficiency (PI) patients with a safe and effective alternative to other immunoglobulin therapies when given in equivalent doses, according to Phase III pivotal trial data presented today at the XIVth Meeting of the European Society for Immunodeficiencies (ESID).
No Comments »
Filed under: Pharmacy News
A vaccine that turns the immune system against brain tumor cells bearing a genetic mutation that drives the most aggressive form of glioblastoma multiforme improved survival of patients in a phase II clinical trial, researchers at Duke University and The University of Texas MD Anderson Cancer Center reported today in the Journal of Clinical Oncology.
No Comments »
Filed under: Pharmacy News
